Quarterly report pursuant to Section 13 or 15(d)

Stock-Based Compensation, Stock Options, Restricted Stock Units and Warrants (Details) - Schedule of Activity Under the 2016 and 2020 Plans

v3.23.2
Stock-Based Compensation, Stock Options, Restricted Stock Units and Warrants (Details) - Schedule of Activity Under the 2016 and 2020 Plans - USD ($)
 6 Months Ended 12 Months Ended
Jun. 30, 2023
Dec. 31, 2022
Schedule Of Activity Under The2016 And2020 Plans Abstract    
Shares Underlying Options, Outstanding at Beginning Balance 159,295
Weighted Average Exercise Price, Outstanding at Beginning Balance $ 153.35
Weighted Average Remaining Contractual Term (Years), Outstanding at Beginning Balance  
Aggregate Intrinsic Value, Outstanding at Beginning Balance  
Shares Underlying Options, Granted  
Weighted Average Exercise Price, Granted  
Weighted Average Remaining Contractual Term (Years), Granted  
Aggregate Intrinsic Value, Granted  
Shares Underlying Options, Canceled  
Weighted Average Exercise Price, Canceled  
Weighted Average Remaining Contractual Term (Years), Canceled  
Aggregate Intrinsic Value, Canceled  
Shares Underlying Options, Forfeited (1,516)
Weighted Average Exercise Price, Forfeited $ 196.86
Weighted Average Remaining Contractual Term (Years), Forfeited
Aggregate Intrinsic Value, Forfeited  
Shares Underlying Options, Outstanding at Ending Balance 157,779 159,295
Weighted Average Exercise Price, Outstanding at Ending Balance $ 157.47 $ 153.35
Weighted Average Remaining Contractual Term (Years), Outstanding at Ending Balance 6 years 6 years 6 months
Aggregate Intrinsic Value, Outstanding at Ending Balance $ 26,188
Shares Underlying Options, Exercisable 142,884  
Weighted Average Exercise Price, Weighted Average Exercise Price, Exercisable $ 167.85  
Weighted Average Remaining Contractual Term (Years), Exercisable 5 years 8 months 12 days  
Aggregate Intrinsic Value, Exercisable